Interaction between Atrial Fibrillation and Heart Failure: Recent Advances
Abstract
A continuous relationship exists between atrial fibrillation and heart failure, where each condition can cause or exacerbate the other. Determining which condition occurs first can pose a significant challenge, as they share various risk factors and intrinsically related pathophysiology. Such is their correlation that a prevalence nearing 60% of atrial fibrillation in de novo heart failure patients and a 37% prevalence of heart failure in newly occurring atrial fibrillation patients have been reported. These conditions have a negative synergistic effect on quality of life, exercise capacity, and hospital readmission. Significant advances have been made in recent years in the diagnosis and treatment of atrial fibrillation and heart failure, with recent guidelines from the American Heart Association (AHA) guidelines, all aimed at establishing comprehensive treatment leading to beneficial cardiovascular outcomes.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.